Document is current

Any future updates will be listed below

Repotrectinib is a next-generation TKI for NTRK fusion-positive solid tumours

Crossref DOI link: https://doi.org/10.1038/s41571-026-01136-z

Published Online: 2026-02-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark